Gene · 839
NIH grants1,719
NIH grants whose papers are about the gene, through NIH's grant-paper links.
721 to 740 of 1,719
Download this page as JSON| Grant | Title | CASP6 papers | Newest fiscal year |
|---|---|---|---|
| P01AG007996 | Studies of Joint Aging and Osteoarthritis | 1 | 2016 |
| P01CA095426 | Innate Immunity: Elucidation and Modulation for Cancer Therapy | 1 | 2016 |
| P01HD029587 | Cellular/Molecular Pathophysiology of Intellectual and Developmental Disabilities | 1 | 2016 |
| P01HD048721 | Mechanisms of Health Effects of Exercise in Children | 1 | 2016 |
| P20GM103534 | Quantitative Biology Research Institute | 1 | 2016 |
| P20MD000175 | NCCU Center for Translational Health Equality Research | 1 | 2016 |
| P20MD006988 | Loma Linda University Center for Health Disparities Research | 1 | 2016 |
| P30EY020799 | Core Grant for Vision Research | 1 | 2016 |
| P50AI098639 | Pathogenesis, Carcinogenesis and Ecology of Opisthorchiasis in Thailand | 1 | 2016 |
| R01AG019206 | Synaptic toxicity of Huntington disease protein | 1 | 2016 |
| R01AG025970 | Gamma-secretase cleavage of the p75 receptor | 1 | 2016 |
| R01AG043379 | Brain and Spinal Cord Microvascular Pathology in Late-Life Motor Impairment | 1 | 2016 |
| R01AI044828 | Survival Function of the Fadd-Caspase-8-Flip Complex | 1 | 2016 |
| R01AI101041 | Allosteric Costimulatory Blockade | 1 | 2016 |
| R01AR055650 | Biological Strategies to Mitigate the Adverse Effects of Polymeric Wear Particles | 1 | 2016 |
| R01AR060782 | Inflammasome Danger Signaling:A Novel Target to Prevent Debris Induced Osteolysis | 1 | 2016 |
| R01AR062123 | DUX4 and the P53 pathway in FSHD pathogenesis | 1 | 2016 |
| R01CA125618 | Gene expression programs of lactic acidosis in human cancers | 1 | 2016 |
| R01CA166294 | Regulation of Mdmx stability and subcellular localization by ubiquitination | 1 | 2016 |
| R01CA167824 | Whole Genome Sequencing to Discover Familial Myeloma Risk Genes | 1 | 2016 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/839/grants?page=37